Voyager Therapeutics: 3Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Wednesday reported a loss of $20.3 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 63 cents.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 78 cents per share.
The gene therapy company posted revenue of $2.1 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $3 million.
Voyager Therapeutics shares have declined 16 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $13.99, a climb of roughly 5 percent in the last 12 months.